FDA Raises Manufacturing Concerns, But ACHV’s Cytisinicline Shows Strong Clinical Profile—Next Steps Expected in 2026
Market Chameleon (Mon, 22-Jun 8:58 AM)
ACHV Secures Major $354M Financing and Targets 2027 US Launch for Smoking Cessation Therapy
Market Chameleon (Tue, 12-May 7:10 AM)
